PL2702164T3 - Sposób obniżania heterogeniczności przeciwciał i sposób ich wytwarzania - Google Patents
Sposób obniżania heterogeniczności przeciwciał i sposób ich wytwarzaniaInfo
- Publication number
- PL2702164T3 PL2702164T3 PL12777325T PL12777325T PL2702164T3 PL 2702164 T3 PL2702164 T3 PL 2702164T3 PL 12777325 T PL12777325 T PL 12777325T PL 12777325 T PL12777325 T PL 12777325T PL 2702164 T3 PL2702164 T3 PL 2702164T3
- Authority
- PL
- Poland
- Prior art keywords
- antibodies
- producing
- reducing heterogeneity
- heterogeneity
- reducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1483CH2011 | 2011-04-29 | ||
| PCT/IB2012/052114 WO2012147053A1 (en) | 2011-04-29 | 2012-04-27 | A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof |
| EP12777325.7A EP2702164B8 (en) | 2011-04-29 | 2012-04-27 | A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2702164T3 true PL2702164T3 (pl) | 2016-06-30 |
Family
ID=47071657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12777325T PL2702164T3 (pl) | 2011-04-29 | 2012-04-27 | Sposób obniżania heterogeniczności przeciwciał i sposób ich wytwarzania |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9631216B2 (pl) |
| EP (1) | EP2702164B8 (pl) |
| KR (1) | KR101591671B1 (pl) |
| CN (1) | CN104024423B (pl) |
| DK (1) | DK2702164T3 (pl) |
| ES (1) | ES2560470T3 (pl) |
| MY (1) | MY169935A (pl) |
| PL (1) | PL2702164T3 (pl) |
| RU (1) | RU2580020C2 (pl) |
| WO (1) | WO2012147053A1 (pl) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY163081A (en) * | 2010-12-28 | 2017-08-15 | Chugai Pharmaceutical Co Ltd | Animal cell culturing method |
| WO2012149197A2 (en) | 2011-04-27 | 2012-11-01 | Abbott Laboratories | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| US9631216B2 (en) | 2011-04-29 | 2017-04-25 | Biocon Research Limited | Method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof |
| US9181572B2 (en) * | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
| PL3489254T3 (pl) | 2012-04-30 | 2023-01-30 | Biocon Limited | Ukierunkowujące/immunomodulujące białko fuzyjne i sposoby jego otrzymywania |
| US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
| HK1211981A1 (en) | 2012-09-02 | 2016-06-03 | Abbvie Inc. | Methods to control protein heterogeneity |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| MY186864A (en) | 2013-03-12 | 2021-08-26 | Biocon Ltd | Fusion immunomodulatory proteins and methods for making same |
| SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| WO2014159579A1 (en) | 2013-03-14 | 2014-10-02 | Abbvie Inc. | MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| PT2970980T (pt) * | 2013-03-15 | 2018-11-19 | Janssen Biotech Inc | Métodos de produção para controlor o teor de lisina c-terminal, galactose e ácido siálico em proteínas recombinantes |
| WO2014182658A1 (en) * | 2013-05-06 | 2014-11-13 | Abbvie Inc. | Compositions for cell culture and methods of using the same |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| KR101867134B1 (ko) * | 2015-03-23 | 2018-06-12 | 한양대학교 산학협력단 | 포유류 세포를 이용하여 목적 물질을 고효율로 생산하기 위한 세포 배양 배지, 이를 이용한 세포 배양 방법 및 목적 물질의 생산 방법 |
| EP3500586B1 (en) | 2016-10-17 | 2021-02-24 | Enzene Biosciences Ltd. | Continuous process for reducing heterogeneity of therapeutic protein |
| EP3947632A1 (en) | 2019-04-01 | 2022-02-09 | The Automation Partnership (Cambridge) Ltd. | Operation process for a cell cultivation system |
| TW202112819A (zh) * | 2019-06-10 | 2021-04-01 | 美商千禧製藥公司 | 用於抗體製備之細胞培養方法及組合物 |
| WO2021066772A1 (en) * | 2019-10-01 | 2021-04-08 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Cell culture medium for reducing fucosylation and basic variants in the production of antibodies |
| IL309560B2 (en) | 2019-12-06 | 2025-05-01 | Regeneron Pharma | Anti-VEGF protein preparations and methods for their production |
| CN116334007A (zh) * | 2023-04-10 | 2023-06-27 | 珠海市丽珠单抗生物技术有限公司 | 一种慢病毒的包装方法 |
| IL328989A (en) * | 2024-01-23 | 2026-08-01 | Amgen Inc | Methods for cargo variant modulation of monoclonal antibodies |
| CN118240744B (zh) * | 2024-03-06 | 2024-11-26 | 上海迈邦生物科技有限公司 | 一种同时调节细胞表达产物聚体、电荷异质性和提高产量的方法 |
| CN118957010B (zh) * | 2024-09-03 | 2025-04-01 | 上海多宁生物科技股份有限公司 | 一种降低碱性峰的cho细胞单克隆抗体制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| WO1990003430A1 (en) | 1988-09-23 | 1990-04-05 | Cetus Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US6048728A (en) * | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| US5126250A (en) * | 1988-09-28 | 1992-06-30 | Eli Lilly And Company | Method for the reduction of heterogeneity of monoclonal antibodies |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
| US5705364A (en) | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| US6528286B1 (en) | 1998-05-29 | 2003-03-04 | Genentech, Inc. | Mammalian cell culture process for producing glycoproteins |
| DE69929198T2 (de) | 1998-05-29 | 2006-08-10 | Genentech, Inc., South San Francisco | Zellkulturverfahren für die produktion von glycoproteinen |
| US20030087372A1 (en) | 2001-06-13 | 2003-05-08 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
| NZ542585A (en) | 2003-05-09 | 2007-11-30 | Crucell Holland Bv | Cultures of PER.C6-immortalized cells and processes for culturing the same to increase product yields therefrom |
| US7294484B2 (en) | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
| US7300773B2 (en) | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
| EP1805320B1 (en) * | 2004-10-22 | 2014-09-03 | Amgen Inc. | Methods for refolding of recombinant antibodies |
| ES2361559T3 (es) * | 2004-11-02 | 2011-06-20 | Ares Trading S.A. | Medio de cultivo de células exento de suero para mamíferos. |
| EP1824964A4 (en) * | 2004-11-19 | 2009-04-01 | Biogen Idec Inc | METHODS FOR PRODUCING MAMMAL CELLS |
| US20070190057A1 (en) | 2006-01-23 | 2007-08-16 | Jian Wu | Methods for modulating mannose content of recombinant proteins |
| DK2041270T3 (da) | 2006-07-13 | 2014-01-27 | Wyeth Llc | Fremstilling af glycoproteiner |
| FI2343362T4 (fi) * | 2006-07-14 | 2024-07-04 | Patheon Holdings I B V | Parannettu menetelmä solujen viljelyä varten |
| MX2009004519A (es) | 2006-11-03 | 2009-05-12 | Wyeth Corp | Sustancias que inhiben la glucolisis en un cultivo de celulas. |
| EP2031064A1 (de) | 2007-08-29 | 2009-03-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Steigerung von Proteintitern |
| CA2717614A1 (en) * | 2008-03-11 | 2009-09-17 | Genentech, Inc. | Antibodies with enhanced adcc function |
| EP2283043B1 (en) | 2008-04-07 | 2014-08-13 | Bayer HealthCare, LLC | Methods of recombinant production of glycoproteins |
| WO2010017338A1 (en) | 2008-08-06 | 2010-02-11 | Praxair Technology, Inc. | METHOD FOR CONTROLLING pH, OSMOLALITY AND DISSOLVED CARBON DIOXIDE LEVELS IN A MAMMALIAN CELL CULTURE PROCESS TO ENHANCE CELL VIABILITY AND BIOLOGIC PRODUCT YIELD |
| RU2011116319A (ru) | 2008-09-26 | 2012-11-10 | Шеринг Корпорейшн (US) | Производство высокого титра антител |
| CA2759370C (en) * | 2009-04-30 | 2020-02-11 | Peter Schotte | Method for the production of domain antibodies |
| CN102511007B (zh) * | 2009-10-02 | 2015-04-15 | 罗切格利卡特公司 | 抗体中的a-岩藻糖基化检测 |
| US9631216B2 (en) | 2011-04-29 | 2017-04-25 | Biocon Research Limited | Method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof |
-
2012
- 2012-04-27 US US14/114,639 patent/US9631216B2/en active Active
- 2012-04-27 CN CN201280031457.8A patent/CN104024423B/zh active Active
- 2012-04-27 WO PCT/IB2012/052114 patent/WO2012147053A1/en not_active Ceased
- 2012-04-27 MY MYPI2013003938A patent/MY169935A/en unknown
- 2012-04-27 RU RU2013152982/10A patent/RU2580020C2/ru active
- 2012-04-27 DK DK12777325.7T patent/DK2702164T3/en active
- 2012-04-27 ES ES12777325.7T patent/ES2560470T3/es active Active
- 2012-04-27 PL PL12777325T patent/PL2702164T3/pl unknown
- 2012-04-27 KR KR1020137031894A patent/KR101591671B1/ko active Active
- 2012-04-27 EP EP12777325.7A patent/EP2702164B8/en not_active Revoked
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013152982A (ru) | 2015-06-10 |
| ES2560470T3 (es) | 2016-02-19 |
| CN104024423A (zh) | 2014-09-03 |
| CN104024423B (zh) | 2017-03-15 |
| US9631216B2 (en) | 2017-04-25 |
| EP2702164B1 (en) | 2015-11-25 |
| DK2702164T3 (en) | 2016-02-01 |
| RU2580020C2 (ru) | 2016-04-10 |
| WO2012147053A1 (en) | 2012-11-01 |
| EP2702164A4 (en) | 2014-12-17 |
| MY169935A (en) | 2019-06-18 |
| US20140199729A1 (en) | 2014-07-17 |
| EP2702164A1 (en) | 2014-03-05 |
| KR20140078581A (ko) | 2014-06-25 |
| KR101591671B1 (ko) | 2016-02-04 |
| EP2702164B8 (en) | 2016-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2702164A4 (en) | METHOD FOR REDUCING ANTIBODY HETEROGENEITY AND PROCESS FOR PRODUCING THE SAME | |
| ZA201401133B (en) | Method for producing ternesite | |
| GB2493999B (en) | Microorganism having enhanced l-valine productivity and method for producing l-valine using the same | |
| EP2762461A4 (en) | CHEMICALLY REINFORCED GLASS AND METHOD FOR THE PRODUCTION THEREOF | |
| EP2668023A1 (en) | Method and apparatus for producing contoured composite structures and structures produced thereby | |
| PT2586600T (pt) | Método e aparelho para produzir enchimentos compósitos | |
| SG11201400405TA (en) | Caninised antibodies and method for the production of same | |
| ZA201308148B (en) | Silencer and a method for producing same | |
| PT2784056T (pt) | Método para a produção seletiva de n-metil-para-anisidina | |
| AP3748A (en) | Method of producing hydrocarbons | |
| SG11201402998PA (en) | Hydroxy-aminopolymers and method for producing same | |
| EP2784156A4 (en) | PROCESS FOR OBTAINING CELLULASE AND DEVICE FOR THIS METHOD | |
| EP2698159A4 (en) | PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF | |
| SG2014014120A (en) | Freshwater production apparatus and method for producing freshwater | |
| SG10201602525RA (en) | Method For Producing Hydrocarbon Material | |
| EP2691494A4 (en) | METHOD AND DEVICE FOR PRODUCING DIESEL | |
| EP2792640A4 (en) | METHOD FOR THE PRODUCTION OF HIGH-PURITY CHLOROPOLYSILANE | |
| SG11201401251TA (en) | Slurry and method for producing slurry | |
| EP2757100A4 (en) | TRIEPOXID COMPOUND AND METHOD FOR THE PRODUCTION THEREOF | |
| SG11201402164SA (en) | Method for producing vinyl acetate | |
| ZA201304447B (en) | Method for producing titano-(silico)-alumino-phosphate | |
| IL231877A0 (en) | A method for the production of dithiene tetracarboximides | |
| ZA201400494B (en) | Apparatus and method for producing shear deformaton | |
| SI2707185T1 (sl) | Obrat za proizvodnjo mavčnih plošč in metoda za proizvodnjo mavčnih plošč | |
| EP2679680A4 (en) | L-CYSTEINE PRODUCING BACTERIUM AND PROCESS FOR PRODUCING L-CYSTEINE |